Loading clinical trials...
Loading clinical trials...
A Multicentre Phase II Study of Risk-adjusted Outpatient-based Salvage Therapy for Patients With Relapsed and Refractory Lymphoma
Conditions
Interventions
gemcitabine, vinorelbine, ifosfamide, filgastrim
gemcitabine, vinorelbine, filgastrim
Locations
10
Australia
Canberra Hospital
Canberra, Australian Capital Territory, Australia
Royal North Shore Hospital
Sydney, New South Wales, Australia
Mater Adult Hospital
South Brisbane, Queensland, Australia
Royal Hobart Hospital
Hobart, Tasmania, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
The Royal Melbourne Hospital
Melbourne, Victoria, Australia
Start Date
December 1, 2002
Primary Completion Date
February 1, 2008
Completion Date
February 1, 2008
Last Updated
January 8, 2016
NCT06667687
NCT05623982
NCT03314974
NCT05346809
NCT05595447
NCT04586478
Lead Sponsor
Bayside Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions